Inter-laboratory Evaluation of Genomic Signatures for Predicting Carcinogenicity in the Rat Predictive Safety Testing Consortium, Carcinogenicity Working Group
暂无分享,去创建一个
Jiri Aubrecht | Peter Kasper | Jeremy Gollub | Michael McMillian | William B. Mattes | Matthew S. Bogdanffy | David Jacobson-Kram | Andrew J. Olaharski | William R. Foster | Yi Yang | Alex Nie | M. Fielden | Y. Dragan | R. Snyder | D. Halbert | A. Roter | P. Lord | W. Mattes | J. Gollub | J. Aubrecht | N. Roome | P. Nioi | R. Dunn | B. Car | P. Kasper | M. Bogdanffy | M. McMillian | A. Nie | C. Elangbam | Yi Yang | Ronny Fransson-Stehen | S. Adams | W. Foster | Shenjue Chen | P. Rossi | Jamie K. Young | J. Sina | J. Marlowe | H. Martus | A. Olaharski | I. Pardo | R. Perry | Robert T. Dunn | Paul Nioi | Phil Rossi | Richard Perry | Nigel Roome | Hans-Joerg Martus | Joseph F. Sina | Stephen P. Adams | Shen-Jue Chen | Peter Lord | Yvonne Dragan | Mark R. Fielden | Chandi S. Elangbam | A Bruce | Ronny Fransson-Stehen | Donald N. Halbert | Alan H. Roter | Jennifer Marlowe | Ingrid D. R. Pardo | Ron Snyder | Bruce D. Car | A. Bruce | D. Jacobson-Kram
[1] E. E. Obaseiki-Ebor,et al. Aspects of chloroquine mutagenicity. , 1986, Mutation research.
[2] G. Tsujimoto,et al. Altered gene expression of transcriptional regulatory factors in tumor marker-positive cells during chemically induced hepatocarcinogenesis. , 2006, Toxicology letters.
[3] James S MacDonald,et al. Human carcinogenic risk evaluation, part IV: assessment of human risk of cancer from chemical exposure using a global weight-of-evidence approach. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[4] O. Kovalchuk,et al. Effect of long-term tamoxifen exposure on genotoxic and epigenetic changes in rat liver: implications for tamoxifen-induced hepatocarcinogenesis. , 2005, Carcinogenesis.
[5] Vicki L Dellarco,et al. Mode of action in relevance of rodent liver tumors to human cancer risk. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[6] T Sofuni,et al. ICH-harmonised guidances on genotoxicity testing of pharmaceuticals: evolution, reasoning and impact. , 1999, Mutation research.
[7] Philip G Hewitt,et al. Acute hepatotoxicity: a predictive model based on focused illumina microarrays. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[8] H. Tomita,et al. Relationship between hepatic gene expression profiles and hepatotoxicity in five typical hepatotoxicant-administered rats. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[9] J W Green,et al. A review of the genotoxicity of marketed pharmaceuticals. , 2001, Mutation research.
[10] Hanlee P. Ji,et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. , 2006, Nature biotechnology.
[11] M. Fielden,et al. A gene expression biomarker provides early prediction and mechanistic assessment of hepatic tumor induction by nongenotoxic chemicals. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.